We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Monoclonal

News List

Calypso Enters into Agreement to Be Acquired by Novartis B3C newswire
January 08, 2024
Calypso is a European biotech translating Interleukin-15 biology into medical breakthroughs by developing CALY-002, an anti-IL-15 monoclonal antibody, for an array of autoimmuneindications
Creating a modern landscape europeanpharmaceuticalreview
May 17, 2019
There are many business challenges to developing a biologics drug, one of which is effective data management.
Aduro Biotech Appoints CMO contractpharma
April 23, 2019
Nuyten brings expertise as a radiation oncologist specializing in cancer biology...
Isotype-specific secondary antibodies for improved signal detection cphi-online
April 12, 2019
Offer an alternative to cross-adsorbed secondary antibodies when absolute specificity is required...